HomeSPRINT • STO
add
Sprint Bioscience AB
Previous close
kr 2.18
Day range
kr 2.04 - kr 2.21
Year range
kr 0.36 - kr 2.35
Market cap
226.86M SEK
Avg Volume
869.10K
P/E ratio
2.17
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 133.91M | 698.65% |
Operating expense | 15.31M | 9.94% |
Net income | 113.17M | 2,787.58% |
Net profit margin | 84.52 | 436.60% |
Earnings per share | — | — |
EBITDA | 117.81M | 3,058.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 126.70M | 405.68% |
Total assets | 136.66M | 224.96% |
Total liabilities | 17.48M | -46.67% |
Total equity | 119.18M | — |
Shares outstanding | 105.52M | — |
Price to book | 1.93 | — |
Return on assets | 371.73% | — |
Return on capital | 469.26% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 113.17M | 2,787.58% |
Cash from operations | 115.84M | 1,992.24% |
Cash from investing | -26.00K | 95.19% |
Cash from financing | -62.00K | — |
Net change in cash | 115.76M | 1,837.28% |
Free cash flow | 73.14M | 1,574.44% |
About
Founded
2009
Website
Employees
30
